Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies.

Faupel-Badger JM, Wang Y, Staff AC, Karumanchi SA, Stanczyk FZ, Pollak M, Hoover RN, Troisi R.

Cancer Causes Control. 2012 May;23(5):779-84. doi: 10.1007/s10552-012-9934-9. Epub 2012 Mar 15.

2.

Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies.

Troisi R, Braekke K, Harsem NK, Hyer M, Hoover RN, Staff AC.

Am J Obstet Gynecol. 2008 Dec;199(6):653.e1-10. doi: 10.1016/j.ajog.2008.06.030. Epub 2008 Aug 22.

3.

Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis.

Faupel-Badger JM, Wang Y, Karumanchi SA, Stanczyk F, Pollak M, McElrath T, Hoover RN, Troisi R.

Cancer Causes Control. 2011 Nov;22(11):1587-95. doi: 10.1007/s10552-011-9835-3. Epub 2011 Sep 24.

4.

Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates.

Agurs-Collins T, Rohrmann S, Sutcliffe C, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G, Rifai N, Pollak MN, Platz EA.

Cancer Causes Control. 2012 Mar;23(3):445-54. doi: 10.1007/s10552-011-9893-6. Epub 2012 Jan 18.

5.
6.

Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia.

Tobinaga CM, Torloni MR, Gueuvoghlanian-Silva BY, Pendeloski KP, Akita PA, Sass N, Daher S.

Acta Obstet Gynecol Scand. 2014 May;93(5):469-76. doi: 10.1111/aogs.12366.

PMID:
24580069
7.

Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.

Stampalija T, Chaiworapongsa T, Romero R, Chaemsaithong P, Korzeniewski SJ, Schwartz AG, Ferrazzi EM, Dong Z, Hassan SS.

J Matern Fetal Neonatal Med. 2013 Sep;26(14):1359-70. doi: 10.3109/14767058.2013.784256. Epub 2013 May 20.

PMID:
23488689
8.

Circulating angiogenic factors and their association with birth outcomes in preeclampsia.

Kulkarni AV, Mehendale SS, Yadav HR, Kilari AS, Taralekar VS, Joshi SR.

Hypertens Res. 2010 Jun;33(6):561-7. doi: 10.1038/hr.2010.31. Epub 2010 Mar 12.

PMID:
20224572
9.

Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates.

Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G, Rifai N, Pollak MN, Agurs-Collins T, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1484-91. doi: 10.1158/1055-9965.EPI-08-0817.

10.

Angiogenic factors and preeclampsia.

Tjoa ML, Levine RJ, Karumanchi SA.

Front Biosci. 2007 Jan 1;12:2395-402. Review.

PMID:
17127249
11.

Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia.

Sezer SD, Küçük M, Yenisey C, Yüksel H, Odabaşı AR, Türkmen MK, Çetinkaya Çakmak B, Ömürlü IK.

Gynecol Endocrinol. 2012 Aug;28(8):628-32. doi: 10.3109/09513590.2011.650759. Epub 2012 Mar 20.

PMID:
22429154
12.

Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.

Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D.

Clin Sci (Lond). 2007 Jan;112(1):51-7.

PMID:
16928195
13.

Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.

Staff AC, Braekke K, Johnsen GM, Karumanchi SA, Harsem NK.

Am J Obstet Gynecol. 2007 Aug;197(2):176.e1-6.

PMID:
17689641
14.

Circulating angiogenic factors in singleton vs multiple-gestation pregnancies.

Maynard SE, Moore Simas TA, Solitro MJ, Rajan A, Crawford S, Soderland P, Meyer BA.

Am J Obstet Gynecol. 2008 Feb;198(2):200.e1-7. doi: 10.1016/j.ajog.2007.08.042.

PMID:
18226624
15.

Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, Hassan SS, Chaiworapongsa T.

J Matern Fetal Neonatal Med. 2015;28(14):1621-32. doi: 10.3109/14767058.2014.964676. Epub 2014 Oct 28.

16.

Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.

Catarino C, Rebelo I, Belo L, Rocha S, Castro EB, Patrício B, Quintanilha A, Santos-Silva A.

Growth Factors. 2009 Dec;27(6):345-51. doi: 10.3109/08977190903184670.

PMID:
19919522
17.

Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.

Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y.

Am J Obstet Gynecol. 2006 Feb;194(2):551-6.

PMID:
16458660
18.

Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile.

Procopciuc LM, Caracostea G, Zaharie G, Stamatian F.

J Matern Fetal Neonatal Med. 2014 Nov;27(17):1754-60. doi: 10.3109/14767058.2014.942625. Epub 2014 Jul 28.

PMID:
25007988
19.

Angiogenic biomarkers in pregnancy: defining maternal and fetal health.

Rasmussen LG, Lykke JA, Staff AC.

Acta Obstet Gynecol Scand. 2015 Aug;94(8):820-32. doi: 10.1111/aogs.12629. Epub 2015 Mar 31. Review.

PMID:
25753566
20.

Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments.

Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F.

J Clin Endocrinol Metab. 2000 May;85(5):1828-33.

PMID:
10843160

Supplemental Content

Support Center